Biomarkers of latent tuberculosis infection
US10935549B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 14, 2019 |
| Grant date | Mar 2, 2021 |
| Priority date | — |
| Expiry date | Jan 14, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/70
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides biomarkers, methods and kits for diagnosing latent tuberculosis (TB) in a subject exposed to TB, and methods and kits for monitoring the effectiveness of treatment for latent TB.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.